Intellectual Property

Our Patents

Luminus maintains a very strong global intellectual property position in U.S., Japan, EU and other countries. The patent applications cover the Company’s LASSN™ nanotechnology platform and its drug development efforts. Luminus has additional patent applications pending that cover LASSN™ drugs that are in its development pipeline. Current coverage extends through 2033 and we are continually inventing and protecting new inventions which will expand and extend coverage beyond 2034.

View US Patent# US8728527